Crystal Structures of Metallo-β-Lactamase (IMP-1) and Its D120E Mutant in Complexes with Citrate and the Inhibitory Effect of the Benzyl Group in Citrate Monobenzyl Ester

J Med Chem. 2021 Jul 22;64(14):10019-10026. doi: 10.1021/acs.jmedchem.1c00308. Epub 2021 Jul 9.

Abstract

The emergence and rapid spread of carbapenem-resistant pathogens producing metallo-β-lactamases such as IMP-1 and NDM-1 have been of great concern in the global clinical setting. The X-ray crystal structures of IMP-1 from Serratia marcescens and its single mutant, D120E, in complexes with citrate were determined at resolutions of 2.00 and 1.85 Å, respectively. Two crystal structures indicate that a single mutation at position 120 caused a structural change around Zn1, where the geometry changes from a tetrahedron in the native IMP-1 to a square pyramid in D120E. Based on these two complex structures, the authors synthesized citrate monobenzyl ester 1 to evaluate the structural requirement for the inhibitory activity against IMP-1 and compared the inhibitory activities with nonsubstituted citrate. The introduction of a benzyl group into citrate enhanced the inhibitory activity in comparison to citrate (IC50 > 5 mM).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Benzyl Compounds / chemistry
  • Benzyl Compounds / pharmacology*
  • Citric Acid / chemistry
  • Citric Acid / pharmacology*
  • Dose-Response Relationship, Drug
  • Esters / chemistry
  • Esters / pharmacology*
  • Humans
  • Molecular Docking Simulation
  • Molecular Structure
  • Mutation
  • RNA-Binding Proteins / antagonists & inhibitors*
  • RNA-Binding Proteins / genetics
  • RNA-Binding Proteins / metabolism
  • Structure-Activity Relationship

Substances

  • Benzyl Compounds
  • Esters
  • IGF2BP1 protein, human
  • RNA-Binding Proteins
  • Citric Acid